CLIN
Folashade Jose, MD
Levine Children's Hospital
Lauren Lazar, MD
UT Southwestern
Cystic fibrosis (CF) is increasingly recognized as a multisystem disease, with gastrointestinal and hepatic complications emerging as important contributors to overall morbidity. This session will explore the evolving understanding of hepatobiliary involvement in CF, including challenges in diagnosis, monitoring, and treatment in the era of CFTR modulator therapy, in addition to new information on management of enteral nutrition, pancreatic insufficiency, constipation, and distal intestinal obstruction syndrome and meconium ileus in the post-modulator era. The session will also cover complex case discussions and provide a platform for dialogue on future directions in hepatic care for individuals with CF.